Share
YSDS Life Science Podcast
YSDS Life Science Podcasts
Season 1, Ep. 1
•
This episode explores the risks and consequences of cold chain failures, especially for
advanced therapies such as cell and gene treatments. We'll talk about how these
therapies are impacted by shipment disruptions and the importance of early cold chain
planning. The conversation will also touch on collaboration with CDMOs and logistics
providers, as well as broader reflections on where the industry needs to improve.
More episodes
View all episodes
3. YSDS Life Science Podcast
20:57||Season 1, Ep. 3John Coleman, Business Unit Director for Life Science at YSDS and Jim Lund, Chief Business Development Officer at CCRM Nordic, discuss collaboration between all stakeholders within a supply chain.2. YSDS Life Science Podcasts
28:32||Season 1, Ep. 2John Coleman sits down with Niklas Adamsson, Interim CEO & COO at Envirotainer, a global leader in temperature-controlled pharma transport. Every day, Envirotainer ships 2.5 million doses of life-saving medicines and vaccines, helping prevent the $35B lost annually due to shipment failures. Niklas emphasizes that success in this critical industry comes down to people, processes, and technology. Proper training, clear responsibilities, and trust are key to keeping medicines safe and reaching the patients who need them.